Recommendations on eligibility to PRIME scheme - Adopted at the CHMP meeting of 27-30 January 2025
Recommendations on eligibility to PRIME scheme - Adopted at the CHMP meeting of 27-30 January 2025
Recommendations on eligibility to PRIME scheme - Adopted at the CHMP meeting of 27-30 January 2025
List of medicines currently in PRIME scheme
EMA human resources strategy: Priorities 2023-2025
Product Management Service (PMS) webinar on Product User Interface (PUI) edit functionalities for industry users, Online, from 28 January 2025, 10:00 (CET) to 28 January 2025, 12:00 (CET)
Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - December 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 11 December 2024, 09:00 (CET) to 11 December 2024, 10:30 (CET)
Guideline on quality, non-clinical and clinical requirements for investigational advanced therapy medicinal products in clinical trials - Scientific guideline
Veterinary medicines European public assessment report (EPAR): Tolfenamic acid VMD, Tolfenamic acid, Status: Authorised
P/87/2010
Submission deadlines for orphan designations
Questions and answers on implementation of the medical devices and in vitro diagnostic medical devices Regulations ((EU) 2017/745 and (EU) 2017/746) - tracked changes